The biotech building a better, faster, stronger coronavirus vaccine
In January, Barney Graham had a new vaccine ready for testing. Its target was the Nipah virus, which had caused respiratory illness and brain infections in past outbreaks in southeast Asia. Graham, a vaccinologist and deputy director at the U.S. National Institute of Allergy and Infectious Diseases Vaccine Research Center in Bethesda, Maryland, was working with Moderna Therapeutics in Cambridge, Massachusetts, to build a type of vaccine never before approved for use.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063